ArticleCancer management and research2026
Pre-Treatment HBV Activation Modulates Circulating Immune Markers in Hepatocellular Carcinoma Patients Undergoing TACE Plus ICIs and Anti-VEGF Antibodies/TKIs.
Lihao Qin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.